These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11934322)

  • 1. Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration.
    Brown MM; Brown GC; Sharma S; Landy J; Bakal J
    Arch Ophthalmol; 2002 Apr; 120(4):481-4. PubMed ID: 11934322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TTO utility scores measure quality of life in patients with visual morbidity due to diabetic retinopathy or ARMD.
    Shah VA; Gupta SK; Shah KV; Vinjamaram S; Chalam KV
    Ophthalmic Epidemiol; 2004 Feb; 11(1):43-51. PubMed ID: 14977496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility values and diabetic retinopathy.
    Brown MM; Brown GC; Sharma S; Shah G
    Am J Ophthalmol; 1999 Sep; 128(3):324-30. PubMed ID: 10511027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vision-related quality of life in patients with diabetic macular oedema.
    Hariprasad SM; Mieler WF; Grassi M; Green JL; Jager RD; Miller L
    Br J Ophthalmol; 2008 Jan; 92(1):89-92. PubMed ID: 17584999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility values and age-related macular degeneration.
    Brown GC; Sharma S; Brown MM; Kistler J
    Arch Ophthalmol; 2000 Jan; 118(1):47-51. PubMed ID: 10636413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vision and quality-of-life.
    Brown GC
    Trans Am Ophthalmol Soc; 1999; 97():473-511. PubMed ID: 10703139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Converting visual acuity to utilities.
    Sharma S; Brown GC; Brown MM; Shah GK; Snow K; Brown H; Hollands H
    Can J Ophthalmol; 2000 Aug; 35(5):267-72. PubMed ID: 10959467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-field photography can identify patients with vision-threatening diabetic retinopathy: a screening approach in the primary care setting.
    Stellingwerf C; Hardus PL; Hooymans JM
    Diabetes Care; 2001 Dec; 24(12):2086-90. PubMed ID: 11723088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of age-related macular degeneration on health status utility values.
    Espallargues M; Czoski-Murray CJ; Bansback NJ; Carlton J; Lewis GM; Hughes LA; Brand CS; Brazier JE
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4016-23. PubMed ID: 16249475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between vision impairment and eye disease to vision-specific quality of life and function in rural India: the Aravind Comprehensive Eye Survey.
    Nirmalan PK; Tielsch JM; Katz J; Thulasiraj RD; Krishnadas R; Ramakrishnan R; Robin AL
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2308-12. PubMed ID: 15980215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: proyecto VER.
    Broman AT; Munoz B; Rodriguez J; Sanchez R; Quigley HA; Klein R; Snyder R; West SK
    Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3393-8. PubMed ID: 12407148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative contributions of reduced vision and general health to NEI-VFQ scores in patients with neovascular age-related macular degeneration.
    Miskala PH; Bressler NM; Meinert CL
    Arch Ophthalmol; 2004 May; 122(5):758-66. PubMed ID: 15136325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-reported utilities in bilateral visual impairment from amblyopia and age-related macular degeneration.
    van de Graaf ES; Despriet DDG; Klaver CCW; Simonsz HJ
    BMC Ophthalmol; 2016 May; 16(1):56. PubMed ID: 27184381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative power of reading tests to differentiate visual impairment caused by cataract and age-related macular degeneration.
    Stifter E; Weghaupt H; Benesch T; Thaler A; Radner W
    J Cataract Refract Surg; 2005 Nov; 31(11):2111-9. PubMed ID: 16412924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilities associated with diabetic retinopathy: results from a Canadian sample.
    Sharma S; Oliver-Fernandez A; Bakal J; Hollands H; Brown GC; Brown MM
    Br J Ophthalmol; 2003 Mar; 87(3):259-61. PubMed ID: 12598432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: a systematic review.
    Poku E; Brazier J; Carlton J; Ferreira A
    BMC Ophthalmol; 2013 Dec; 13():74. PubMed ID: 24304921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparities between Ophthalmologists and Patients in Estimating Quality of Life Associated with Diabetic Retinopathy.
    Zhu X; Sun Q; Zou H; Xu X; Zhang X
    PLoS One; 2015; 10(12):e0143678. PubMed ID: 26630653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual acuity comparison of vitrectomy with and without internal limiting membrane removal in the treatment of diabetic macular edema.
    Bahadir M; Ertan A; Mertoğlu O
    Int Ophthalmol; 2005; 26(1-2):3-8. PubMed ID: 16786177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
    ; Gross JG; Glassman AR; Jampol LM; Inusah S; Aiello LP; Antoszyk AN; Baker CW; Berger BB; Bressler NM; Browning D; Elman MJ; Ferris FL; Friedman SM; Marcus DM; Melia M; Stockdale CR; Sun JK; Beck RW
    JAMA; 2015 Nov; 314(20):2137-2146. PubMed ID: 26565927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual acuity measurement and ocular co-morbidity in diabetic retinopathy screening.
    Scanlon PH; Foy C; Chen FK
    Br J Ophthalmol; 2008 Jun; 92(6):775-8. PubMed ID: 18356262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.